Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2012-09-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-012-1390-7PMID 22983311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 15. CADDRA. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). 3rd ed. Toronto, ON: Canadian ADHD Practice Guidelines; 2011.

  2014cited by this paper
• Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

  2013cited by this paper
• Meta-analysis in context.

  2012cited by this paper
• Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate

  2012cited by this paper
• Australian National Trends in Stimulant Dispensing: 2002–2009

  2011cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2011cited by this paper
• Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder

  2011cited by this paper
• Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

  2011cited by this paper
• Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder

  2011cited by this paper
• Attention deficit hyperactivity disorder in adults

  2010cited by this paper
• European guidelines on managing adverse effects of medication for ADHD

  2010cited by this paper
• Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

  2010cited by this paper
• Imaging in patients with breast implants—results of the First International Breast (Implant) Conference 2009

  2010cited by this paper
• Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder

  2010cited by this paper
• A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

  2010cited by this paper
• Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate

  2010cited by this paper
• A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

  2010cited by this paper
• Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

  2009cited by this paper
• Sudden death and use of stimulant medications in youths.

  2009cited by this paper
• Safety of therapeutic methylphenidate in adults: a systematic review of the evidence

  2009cited by this paper
• Safety of stimulant treatment in attention deficit hyperactivity disorder: part I

  2009cited by this paper
• A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

  2009cited by this paper
• Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006.

  2009cited by this paper
• Safety of stimulant treatment in attention deficit hyperactivity disorder: part II

  2009cited by this paper
• Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation Study

  2009cited by this paper
• Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder

  2009cited by this paper
• Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

  2008cited by this paper
• A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

  2008cited by this paper
• A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

  2008cited by this paper
• Problems and Limitations in Conducting Systematic Reviews

  2008cited by this paper
• Long-acting medications for the hyperkinetic disorders

  2007cited by this paper
• Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

  2007cited by this paper
• Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder.

  2007cited by this paper
• A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.

  2007cited by this paper
• Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

  2007cited by this paper
• Long-acting medications for the hyperkinetic disorders

  2006cited by this paper
• A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

  2006cited by this paper
• Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community.

  2006cited by this paper
• Effectiveness outcomes in attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Pharmacotherapy of adult ADHD.

  2005cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder

  2005cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.

  2005cited by this paper
• Effects of Once-Daily Osmotic-Release Methylphenidate on Blood Pressure and Heart Rate in Children with Attention-Deficit/Hyperactivity Disorder: Results from a One-Year Follow-up Study

  2004cited by this paper
• Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Attention-Deficit/Hyperactivity Disorder in Adults

  2004influential reference
• Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder

  2003cited by this paper
• Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning

  2002cited by this paper
• Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence.

  2002cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2002cited by this paper
• Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.

  2001cited by this paper
• A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

  2000cited by this paper
• Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study.

  1998cited by this paper
• A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

  1995cited by this paper
• Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

  1995cited by this paper

• Digital health technologies for adults with ADHD: a scoping review

  2026cites this paper
• Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults

  2025cites this paper
• Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Assessor-Blinded, Controlled Trial

  2025cites this paper
• Discontinuation of methylphenidate after long-term exposure in nonhuman primates.

  2023cites this paper
• Cognitive control enhancement in attention deficit hyperactivity disorder (ADHD) and neurotypical individuals

  2023cites this paper
• A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder

  2023cites this paper
• Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders

  2022cites this paper
• Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

  2022cites this paper
• ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment.

  2021cites this paper
• Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

  2021cites this paper
• [Attention deficit hyperactivity disorder].

  2020cites this paper
• Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial.

  2019cites this paper
• Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

  2018cites this paper
• Transcranial direct current stimulation improves long-term memory deficits in an animal model of attention-deficit/hyperactivity disorder and modulates oxidative and inflammatory parameters

  2018cites this paper
• Null tDCS Effects in a Sustained Attention Task: The Modulating Role of Learning

  2018cites this paper
• Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look

  2018cites this paper
• Context of Psychotropic Drug Delivery Modulates its Neurobehavioral Effects: the Case of Methylphenidate

  2017cites this paper
• Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

  2017cites this paper
• Eficàcia, seguretat i abandonament del tractament farmacològic del trastorn per dèficit d’atenció amb hiperactivitat en pacients adults

  2017influential citation
• Positive effects of transcranial direct current stimulation in adult patients with attention-deficit/hyperactivity disorder - A pilot randomized controlled study.

  2017cites this paper
• A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients

  2016influential citation
• Treatment dropout and missed appointments among adults with attention-deficit/hyperactivity disorder: associations with patient- and disorder-related factors.

  2016cites this paper
• Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review

  2016cites this paper
• Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study

  2016cites this paper
• Alternative pharmacological strategies for adult ADHD treatment: a systematic review

  2016influential citation
• Men with ADHD in compulsory care for substance abuse : characterization and treatment

  2016cites this paper
• Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study

  2016cites this paper
• Trastorno por déficit de atención con hiperactividad

  2015cites this paper
• When ADHD and substance use disorders coexist : etiology and pharmacological treatment

  2015cites this paper
• Attention-deficit/hyperactivity disorder

  2015cites this paper
• Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials

  2015cites this paper
• ReviewAttention deficit hyperactivity disorderTrastorno por déficit de atención con hiperactividad

  2015cites this paper
• Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence

  2015cites this paper
• ADHS im Erwachsenenalter

  2015cites this paper
• Reply to the letter to the editor by Ramos‐Quiroga et al.

  2014cites this paper
• exploratory meta-analysis on lisdexamfetamine versus placebo in adult aDhD

  2014cites this paper
• Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD

  2014cites this paper
• Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression

  2013cites this paper
• P.7.d.012 Paliperidone palmitate long-acting injection in adolescents: report of two cases

  2013cites this paper
• Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers

  2013cites this paper
• Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.

  2013cites this paper
• Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.

  2011cites this paper